'''Katemera wa Hepataitisi A''' ndi [[vaccine|katemera]] amene amathandiza kupewa matenda a [[hepatitis A|hepataitisi A]].<ref name="WHO20122">{{cite journal|title=WHO position paper on hepatitis A vaccines – June 2012.|journal=Wkly Epidemiol Rec|date=2012 Jul 13|volume=87|issue=28/29|page=261-76|pmid=22905367|url=http://www.who.int/wer/2012/wer8728_29.pdf}}</ref> Kafukufuku akusonyeza kuti katemerayu amathandiza kwambiri moti anthu 95 pa 100 aliwonse amene alandira katemerayu sadwala matenda a hepataitisi ndipo katemerayu amagwira ntchito m'thupi kwa zaka zosachepera 15, ndipo kwa anthu ambiri amathandiza kwa moyo wawo wonse.<ref name="Ott20122">{{cite journal|author=Ott JJ, Irving G, Wiersma ST|title=Long-term protective effects of hepatitis A vaccines. A systematic review|journal=Vaccine|volume=31|issue=1|pages=3–11|date=December 2012|pmid=22609026|doi=10.1016/j.vaccine.2012.04.104}}</ref><ref name="WHO20122" /> Madokotala amalimbikitsa kuti munthu ayenera kulandira katemerayu kawiri pa moyo wake kuyambira ali ndi chaka chimodzi.<!-- <ref name=WHO2012/> --> Katemerayu amaperekedwa kudzera mu [[Intramuscular|jakisoni yemwe amabayidwa m'minofu]].<ref name="WHO20122" /><!-- Recommendations -->

The [[World Health Organization]] (WHO) recommends universal vaccination in areas where the diseases is moderately common.<!-- <ref name=WHO2012/> --> Where the disease is very common widespread vaccination is not recommended as all people typically develop immunity through infection when a child.<ref name="WHO20122" /> The [[Center for Disease Control and Prevention]] (CDC) recommends vaccinating adults who are at high risk and all children.<ref>{{cite web|title=Hepatitis A In-Short|url=http://www.cdc.gov/vaccines/vpd-vac/hepa/in-short-adult.htm#who|website=CDC|accessdate=7 December 2015|date=July 25, 2014}}</ref><!-- Safety and formulation-->

Severe side effects are very rare.<!-- <ref name=WHO2012/> --> Pain at the site of injection occurs in about 15% of children and half of adults.<!-- <ref name=WHO2012/> --> Most hepatitis A vaccines contain inactivated virus while a few contain weakened virus.<!-- <ref name=WHO2012/> --> The ones with weakened virus are not recommended during [[pregnancy]] or in those with [[Immunosuppressed|poor immune function]].<!-- <ref name=WHO2012/> --> A few formulations combine hepatitis A with either [[Hepatitis B vaccine|hepatitis B]] or [[typhoid vaccine]].<ref name="WHO20122" /><!-- History, society and culture -->The first hepatitis A vaccine was approved in Europe in 1991 and the United States in 1995.<ref>{{cite book|last1=Patravale|first1=Vandana|last2=Dandekar|first2=Prajakta|last3=Jain|first3=Ratnesh|title=Nanoparticulate drug delivery perspectives on the transition from laboratory to market|date=2012|publisher=Woodhead Pub.|location=Oxford|isbn=9781908818195|page=212|edition=1. publ.|url=https://books.google.ca/books?id=VWdEAgAAQBAJ&pg=PA212}}</ref> It is on the [[World Health Organization's List of Essential Medicines]], the most important medication needed in a basic [[health system]].<ref name="WHO2015E">{{cite web|url=http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf|title=19th WHO Model List of Essential Medicines (April 2015)|date=April 2015|accessdate=May 10, 2015|publisher=WHO}}</ref> In the United States it costs between 50 and 100 USD.<ref name="Ric2015">{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=314}}</ref>

== Malifalensi ==
<references />
[[Category:Pages with unreviewed translations]]
